Index Venture Life Associates VI Ltd

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Index Venture Life Associates VI Ltd reported 1 stock position worth $143.3 million. Its top holding was Centessa Pharmaceuticals (CNTA) at 100.0% of the portfolio. Compared with Q4 2024, it sold out of 1. The biggest sale was an exit from Century Therapeutics (IPSC).

Most Recent 13F
Q2 2026
Location
ST. HELIER, Y9
CIK
0001865139
Portfolio Value
$143.3M (Q1 2025)
SEC Filing
0000950123-25-005527 ↗ filed May 15, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q4 2024: $167.1M Q4 2024 Q1 2025: $143.3M $143.3M Q1 2025 Q2 2025: $130.9M Q2 2025 Q3 2025: $241.6M Q3 2025 Q4 2025: $249.1M Q4 2025 Q1 2026: $395.7M Q1 2026 Q2 2026: $0 Q2 2026

Holdings 1 stocks · $143.3M

CNTA Centessa Pharmaceuticals Ltd. 100.00% 9,961,789 $143.3M No change

Portfolio Sells Q4 2024 → Q1 2025

IPSC Century Therapeutics Inc. Sold out 0.00% −0.11

Portfolio Buys Q4 2024 → Q1 2025

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 0$0
Q1 2026 1$395.7MCNTA
Q4 2025 1$249.1MCNTA
Q3 2025 1$241.6MCNTA
Q2 2025 1$130.9MCNTA
Q1 2025 1$143.3MCNTA
Q4 2024 2$167.1MCNTA, IPSC